CTC Capital Management’s Cano Health, Inc. CANO Stock Holding History

CTC Capital Management’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-152	Closed	-$97K	–	176
2022 Q1	$97K	Buy	+152	New	+$95.8K	0.26%	91

Other funds holding CANO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

CTC Capital Management's CANO Position: Q2 2022 in Review

CTC Capital Management sold out of Cano Health, Inc. (CANO) in Q2 2022, closing a stake of 152 shares — an estimated $97K sold.

CTC Capital Management first reported a position in CANO in Q1 2022 and held it in 1 quarter. The position peaked at $97K in Q1 2022. 144 funds tracked by Wall St. Rank hold CANO as of Q2 2022.

CTC Capital Management reported no remaining Cano Health, Inc. position as of Q2 2022 after selling out during the quarter.
CTC Capital Management sold 152 Cano Health, Inc. shares in Q2 2022, an estimated $97K.
CTC Capital Management first reported a position in Cano Health, Inc. in Q1 2022 and held it in 1 quarter.
CTC Capital Management's Cano Health, Inc. position peaked at $97K in Q1 2022.
144 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q2 2022.

Based on CTC Capital Management's 13F filing for Q2 2022, filed 5 Aug 2022.